Ketorolac Tromethamine Injection — FDA Drug Shortage

Current — Sagent Pharmaceuticals

The FDA lists a drug shortage record for Ketorolac Tromethamine Injection (injection) from Sagent Pharmaceuticals with status Current. The shortage was first posted on Mar 26, 2018. Reported reason: Demand increase for the drug

Shortage details

Status
Current
Company
Sagent Pharmaceuticals
Package NDC
25021-701-02
Dosage Form
Injection
Presentation
Ketorolac Tromethamine, Injection, 30 mg/1 mL (NDC 25021-701-02)
Initial Posting
Mar 26, 2018

Reason

Demand increase for the drug

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.